[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global PROTAC Drug Supply, Demand and Key Producers, 2024-2030

March 2024 | 97 pages | ID: GA8AA149B2F9EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global PROTAC Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

This report studies the global PROTAC Drug demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for PROTAC Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of PROTAC Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global PROTAC Drug total market, 2019-2030, (USD Million)

Global PROTAC Drug total market by region & country, CAGR, 2019-2030, (USD Million)

U.S. VS China: PROTAC Drug total market, key domestic companies and share, (USD Million)

Global PROTAC Drug revenue by player and market share 2019-2024, (USD Million)

Global PROTAC Drug total market by Type, CAGR, 2019-2030, (USD Million)

Global PROTAC Drug total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global PROTAC Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Arvinas, Nurix, Kymera Therapeutics, C4 Therapeutics, Ranok Therapeutics, Accutar Biotechnology, BeiGene Ltd., Hinova Pharmaceuticals and Haisco Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PROTAC Drug market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global PROTAC Drug Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global PROTAC Drug Market, Segmentation by Type
  • Based on CRBN
  • Based on VHL
Global PROTAC Drug Market, Segmentation by Application
  • Cancer
  • Autoimmune Diseases
  • Other
Companies Profiled:
  • Arvinas
  • Nurix
  • Kymera Therapeutics
  • C4 Therapeutics
  • Ranok Therapeutics
  • Accutar Biotechnology
  • BeiGene Ltd.
  • Hinova Pharmaceuticals
  • Haisco Pharmaceutical
Key Questions Answered

1. How big is the global PROTAC Drug market?

2. What is the demand of the global PROTAC Drug market?

3. What is the year over year growth of the global PROTAC Drug market?

4. What is the total value of the global PROTAC Drug market?

5. Who are the major players in the global PROTAC Drug market?
1 SUPPLY SUMMARY

1.1 PROTAC Drug Introduction
1.2 World PROTAC Drug Market Size & Forecast (2019 & 2023 & 2030)
1.3 World PROTAC Drug Total Market by Region (by Headquarter Location)
  1.3.1 World PROTAC Drug Market Size by Region (2019-2030), (by Headquarter Location)
  1.3.2 United States PROTAC Drug Market Size (2019-2030)
  1.3.3 China PROTAC Drug Market Size (2019-2030)
  1.3.4 Europe PROTAC Drug Market Size (2019-2030)
  1.3.5 Japan PROTAC Drug Market Size (2019-2030)
  1.3.6 South Korea PROTAC Drug Market Size (2019-2030)
  1.3.7 ASEAN PROTAC Drug Market Size (2019-2030)
  1.3.8 India PROTAC Drug Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
  1.4.1 PROTAC Drug Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 PROTAC Drug Major Market Trends

2 DEMAND SUMMARY

2.1 World PROTAC Drug Consumption Value (2019-2030)
2.2 World PROTAC Drug Consumption Value by Region
  2.2.1 World PROTAC Drug Consumption Value by Region (2019-2024)
  2.2.2 World PROTAC Drug Consumption Value Forecast by Region (2025-2030)
2.3 United States PROTAC Drug Consumption Value (2019-2030)
2.4 China PROTAC Drug Consumption Value (2019-2030)
2.5 Europe PROTAC Drug Consumption Value (2019-2030)
2.6 Japan PROTAC Drug Consumption Value (2019-2030)
2.7 South Korea PROTAC Drug Consumption Value (2019-2030)
2.8 ASEAN PROTAC Drug Consumption Value (2019-2030)
2.9 India PROTAC Drug Consumption Value (2019-2030)

3 WORLD PROTAC DRUG COMPANIES COMPETITIVE ANALYSIS

3.1 World PROTAC Drug Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global PROTAC Drug Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for PROTAC Drug in 2023
  3.2.3 Global Concentration Ratios (CR8) for PROTAC Drug in 2023
3.3 PROTAC Drug Company Evaluation Quadrant
3.4 PROTAC Drug Market: Overall Company Footprint Analysis
  3.4.1 PROTAC Drug Market: Region Footprint
  3.4.2 PROTAC Drug Market: Company Product Type Footprint
  3.4.3 PROTAC Drug Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: PROTAC Drug Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: PROTAC Drug Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
  4.1.2 United States VS China: PROTAC Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: PROTAC Drug Consumption Value Comparison
  4.2.1 United States VS China: PROTAC Drug Consumption Value Comparison (2019 & 2023 & 2030)
  4.2.2 United States VS China: PROTAC Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based PROTAC Drug Companies and Market Share, 2019-2024
  4.3.1 United States Based PROTAC Drug Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies PROTAC Drug Revenue, (2019-2024)
4.4 China Based Companies PROTAC Drug Revenue and Market Share, 2019-2024
  4.4.1 China Based PROTAC Drug Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies PROTAC Drug Revenue, (2019-2024)
4.5 Rest of World Based PROTAC Drug Companies and Market Share, 2019-2024
  4.5.1 Rest of World Based PROTAC Drug Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies PROTAC Drug Revenue, (2019-2024)

5 MARKET ANALYSIS BY TYPE

5.1 World PROTAC Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
  5.2.1 Based on CRBN
  5.2.2 Based on VHL
5.3 Market Segment by Type
  5.3.1 World PROTAC Drug Market Size by Type (2019-2024)
  5.3.2 World PROTAC Drug Market Size by Type (2025-2030)
  5.3.3 World PROTAC Drug Market Size Market Share by Type (2019-2030)

6 MARKET ANALYSIS BY APPLICATION

6.1 World PROTAC Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
  6.2.1 Cancer
  6.2.2 Autoimmune Diseases
  6.2.3 Other
6.3 Market Segment by Application
  6.3.1 World PROTAC Drug Market Size by Application (2019-2024)
  6.3.2 World PROTAC Drug Market Size by Application (2025-2030)
  6.3.3 World PROTAC Drug Market Size by Application (2019-2030)

7 COMPANY PROFILES

7.1 Arvinas
  7.1.1 Arvinas Details
  7.1.2 Arvinas Major Business
  7.1.3 Arvinas PROTAC Drug Product and Services
  7.1.4 Arvinas PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024)
  7.1.5 Arvinas Recent Developments/Updates
  7.1.6 Arvinas Competitive Strengths & Weaknesses
7.2 Nurix
  7.2.1 Nurix Details
  7.2.2 Nurix Major Business
  7.2.3 Nurix PROTAC Drug Product and Services
  7.2.4 Nurix PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024)
  7.2.5 Nurix Recent Developments/Updates
  7.2.6 Nurix Competitive Strengths & Weaknesses
7.3 Kymera Therapeutics
  7.3.1 Kymera Therapeutics Details
  7.3.2 Kymera Therapeutics Major Business
  7.3.3 Kymera Therapeutics PROTAC Drug Product and Services
  7.3.4 Kymera Therapeutics PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024)
  7.3.5 Kymera Therapeutics Recent Developments/Updates
  7.3.6 Kymera Therapeutics Competitive Strengths & Weaknesses
7.4 C4 Therapeutics
  7.4.1 C4 Therapeutics Details
  7.4.2 C4 Therapeutics Major Business
  7.4.3 C4 Therapeutics PROTAC Drug Product and Services
  7.4.4 C4 Therapeutics PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024)
  7.4.5 C4 Therapeutics Recent Developments/Updates
  7.4.6 C4 Therapeutics Competitive Strengths & Weaknesses
7.5 Ranok Therapeutics
  7.5.1 Ranok Therapeutics Details
  7.5.2 Ranok Therapeutics Major Business
  7.5.3 Ranok Therapeutics PROTAC Drug Product and Services
  7.5.4 Ranok Therapeutics PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024)
  7.5.5 Ranok Therapeutics Recent Developments/Updates
  7.5.6 Ranok Therapeutics Competitive Strengths & Weaknesses
7.6 Accutar Biotechnology
  7.6.1 Accutar Biotechnology Details
  7.6.2 Accutar Biotechnology Major Business
  7.6.3 Accutar Biotechnology PROTAC Drug Product and Services
  7.6.4 Accutar Biotechnology PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024)
  7.6.5 Accutar Biotechnology Recent Developments/Updates
  7.6.6 Accutar Biotechnology Competitive Strengths & Weaknesses
7.7 BeiGene Ltd.
  7.7.1 BeiGene Ltd. Details
  7.7.2 BeiGene Ltd. Major Business
  7.7.3 BeiGene Ltd. PROTAC Drug Product and Services
  7.7.4 BeiGene Ltd. PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024)
  7.7.5 BeiGene Ltd. Recent Developments/Updates
  7.7.6 BeiGene Ltd. Competitive Strengths & Weaknesses
7.8 Hinova Pharmaceuticals
  7.8.1 Hinova Pharmaceuticals Details
  7.8.2 Hinova Pharmaceuticals Major Business
  7.8.3 Hinova Pharmaceuticals PROTAC Drug Product and Services
  7.8.4 Hinova Pharmaceuticals PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024)
  7.8.5 Hinova Pharmaceuticals Recent Developments/Updates
  7.8.6 Hinova Pharmaceuticals Competitive Strengths & Weaknesses
7.9 Haisco Pharmaceutical
  7.9.1 Haisco Pharmaceutical Details
  7.9.2 Haisco Pharmaceutical Major Business
  7.9.3 Haisco Pharmaceutical PROTAC Drug Product and Services
  7.9.4 Haisco Pharmaceutical PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024)
  7.9.5 Haisco Pharmaceutical Recent Developments/Updates
  7.9.6 Haisco Pharmaceutical Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 PROTAC Drug Industry Chain
8.2 PROTAC Drug Upstream Analysis
8.3 PROTAC Drug Midstream Analysis
8.4 PROTAC Drug Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World PROTAC Drug Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World PROTAC Drug Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World PROTAC Drug Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World PROTAC Drug Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World PROTAC Drug Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World PROTAC Drug Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World PROTAC Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World PROTAC Drug Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World PROTAC Drug Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key PROTAC Drug Players in 2023
Table 12. World PROTAC Drug Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global PROTAC Drug Company Evaluation Quadrant
Table 14. Head Office of Key PROTAC Drug Player
Table 15. PROTAC Drug Market: Company Product Type Footprint
Table 16. PROTAC Drug Market: Company Product Application Footprint
Table 17. PROTAC Drug Mergers & Acquisitions Activity
Table 18. United States VS China PROTAC Drug Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China PROTAC Drug Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based PROTAC Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies PROTAC Drug Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies PROTAC Drug Revenue Market Share (2019-2024)
Table 23. China Based PROTAC Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies PROTAC Drug Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies PROTAC Drug Revenue Market Share (2019-2024)
Table 26. Rest of World Based PROTAC Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies PROTAC Drug Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies PROTAC Drug Revenue Market Share (2019-2024)
Table 29. World PROTAC Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World PROTAC Drug Market Size by Type (2019-2024) & (USD Million)
Table 31. World PROTAC Drug Market Size by Type (2025-2030) & (USD Million)
Table 32. World PROTAC Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World PROTAC Drug Market Size by Application (2019-2024) & (USD Million)
Table 34. World PROTAC Drug Market Size by Application (2025-2030) & (USD Million)
Table 35. Arvinas Basic Information, Area Served and Competitors
Table 36. Arvinas Major Business
Table 37. Arvinas PROTAC Drug Product and Services
Table 38. Arvinas PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Arvinas Recent Developments/Updates
Table 40. Arvinas Competitive Strengths & Weaknesses
Table 41. Nurix Basic Information, Area Served and Competitors
Table 42. Nurix Major Business
Table 43. Nurix PROTAC Drug Product and Services
Table 44. Nurix PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Nurix Recent Developments/Updates
Table 46. Nurix Competitive Strengths & Weaknesses
Table 47. Kymera Therapeutics Basic Information, Area Served and Competitors
Table 48. Kymera Therapeutics Major Business
Table 49. Kymera Therapeutics PROTAC Drug Product and Services
Table 50. Kymera Therapeutics PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Kymera Therapeutics Recent Developments/Updates
Table 52. Kymera Therapeutics Competitive Strengths & Weaknesses
Table 53. C4 Therapeutics Basic Information, Area Served and Competitors
Table 54. C4 Therapeutics Major Business
Table 55. C4 Therapeutics PROTAC Drug Product and Services
Table 56. C4 Therapeutics PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. C4 Therapeutics Recent Developments/Updates
Table 58. C4 Therapeutics Competitive Strengths & Weaknesses
Table 59. Ranok Therapeutics Basic Information, Area Served and Competitors
Table 60. Ranok Therapeutics Major Business
Table 61. Ranok Therapeutics PROTAC Drug Product and Services
Table 62. Ranok Therapeutics PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Ranok Therapeutics Recent Developments/Updates
Table 64. Ranok Therapeutics Competitive Strengths & Weaknesses
Table 65. Accutar Biotechnology Basic Information, Area Served and Competitors
Table 66. Accutar Biotechnology Major Business
Table 67. Accutar Biotechnology PROTAC Drug Product and Services
Table 68. Accutar Biotechnology PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Accutar Biotechnology Recent Developments/Updates
Table 70. Accutar Biotechnology Competitive Strengths & Weaknesses
Table 71. BeiGene Ltd. Basic Information, Area Served and Competitors
Table 72. BeiGene Ltd. Major Business
Table 73. BeiGene Ltd. PROTAC Drug Product and Services
Table 74. BeiGene Ltd. PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. BeiGene Ltd. Recent Developments/Updates
Table 76. BeiGene Ltd. Competitive Strengths & Weaknesses
Table 77. Hinova Pharmaceuticals Basic Information, Area Served and Competitors
Table 78. Hinova Pharmaceuticals Major Business
Table 79. Hinova Pharmaceuticals PROTAC Drug Product and Services
Table 80. Hinova Pharmaceuticals PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Hinova Pharmaceuticals Recent Developments/Updates
Table 82. Haisco Pharmaceutical Basic Information, Area Served and Competitors
Table 83. Haisco Pharmaceutical Major Business
Table 84. Haisco Pharmaceutical PROTAC Drug Product and Services
Table 85. Haisco Pharmaceutical PROTAC Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 86. Global Key Players of PROTAC Drug Upstream (Raw Materials)
Table 87. PROTAC Drug Typical Customers
List of Figure
Figure 1. PROTAC Drug Picture
Figure 2. World PROTAC Drug Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World PROTAC Drug Total Market Size (2019-2030) & (USD Million)
Figure 4. World PROTAC Drug Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World PROTAC Drug Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company PROTAC Drug Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company PROTAC Drug Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company PROTAC Drug Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company PROTAC Drug Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company PROTAC Drug Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company PROTAC Drug Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company PROTAC Drug Revenue (2019-2030) & (USD Million)
Figure 13. PROTAC Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World PROTAC Drug Consumption Value (2019-2030) & (USD Million)
Figure 16. World PROTAC Drug Consumption Value Market Share by Region (2019-2030)
Figure 17. United States PROTAC Drug Consumption Value (2019-2030) & (USD Million)
Figure 18. China PROTAC Drug Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe PROTAC Drug Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan PROTAC Drug Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea PROTAC Drug Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN PROTAC Drug Consumption Value (2019-2030) & (USD Million)
Figure 23. India PROTAC Drug Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of PROTAC Drug by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for PROTAC Drug Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for PROTAC Drug Markets in 2023
Figure 27. United States VS China: PROTAC Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: PROTAC Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World PROTAC Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World PROTAC Drug Market Size Market Share by Type in 2023
Figure 31. Based on CRBN
Figure 32. Based on VHL
Figure 33. World PROTAC Drug Market Size Market Share by Type (2019-2030)
Figure 34. World PROTAC Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World PROTAC Drug Market Size Market Share by Application in 2023
Figure 36. Cancer
Figure 37. Autoimmune Diseases
Figure 38. Other
Figure 39. PROTAC Drug Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source


More Publications